Edwards Larry Todd
SEC CIK 1994805 · EDGAR
BoughtSold
Most active insiders at ORKA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir, 10% | — | $300.01M |
| 2 | Dambkowski Carl | Dir | — | $8.65M |
| 3 | Klein Lawrence Otto | CEO, Dir | — | $7.31M |
| 4 | Quinlan Paul T | GC | — | $6.76M |
| 5 | Goncalves Joana | Chief Medical Off | — | $4.54M |
| 6 | Agarwal Arjun | SVP, Fin | — | $4.33M |
| 7 | Sandler Laura Lee | COO | — | $1.94M |
| 8 | Edwards Larry Todd | Chief Commercial Off | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-25 16:25 | 2026-08-24 | ORKA | Oruka Therapeutics, Inc. | Edwards Larry Todd | Chief Commercial Off | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| DM | 2026-03-03 | 2026-03-02 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | See Remarks | S - Sale | $25.18 | -3,687 | 175.2K | -2% | -$92.8K |
| D | 2026-03-03 | 2026-02-27 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | See Remarks | A - Grant | $0.00 | +30.0K | 178.9K | +20% | $0 |
| 2026-02-04 | 2026-02-02 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | See Remarks | S - Sale | $25.50 | -2,052 | 148.9K | -1% | -$52.3K | |
| 2025-11-10 | 2025-11-06 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | See Remarks | S - Sale | $25.16 | -29.1K | 150.2K | -16% | -$732.9K | |
| M | 2025-10-06 | 2025-10-02 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | See Remarks | S - Sale | $20.04 | -4,504 | 179.3K | -2% | -$90.3K |
| 2025-05-20 | 2025-05-19 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | See Remarks | S - Sale | $14.07 | -7,451 | 183.1K | -4% | -$104.8K | |
| DM | 2025-03-04 | 2025-02-28 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | See Remarks | A - Grant | $0.00 | +55.0K | 173.6K | +46% | $0 |
| 2025-02-04 | 2025-02-03 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | See Remarks | S - Sale | $12.70 | -2,173 | 135.6K | -2% | -$27.6K | |
| 2024-12-03 | 2024-11-30 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | See Remarks | P - Purchase | $7.11 | +1,093 | 137.7K | +0.8% | +$7,771 | |
| 2024-10-03 | 2024-10-02 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | SVP Chief Commercial Off | S - Sale | $10.01 | -3,725 | 136.6K | -3% | -$37.3K | |
| 2024-05-20 | 2024-05-16 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | SVP Chief Commercial Off | A - Grant | $0.00 | +60.0K | 148.0K | +68% | $0 | |
| 2024-05-20 | 2024-05-17 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | SVP Chief Commercial Off | S - Sale | $8.98 | -7,640 | 140.4K | -5% | -$68.6K | |
| D | 2024-01-17 | 2024-01-12 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | Chief Commercial Off | A - Grant | $0.00 | +28.0K | 88.0K | +47% | $0 |
| D | 2023-10-03 | 2023-09-27 | ARQT | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd | Chief Commercial Off | A - Grant | $0.00 | +60.0K | 60.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations